Mandy J. Wittens

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Neurosurgeons' perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trials.

Neurosurgeons' perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trials.

Journal: Neuro-oncology advances
Published: May 01, 2026

Real-world brain volumetry in multiple sclerosis: importance of methodological consistency and clinical relevance of gray matter atrophy.

Real-world brain volumetry in multiple sclerosis: importance of methodological consistency and clinical relevance of gray matter atrophy.

Journal: Frontiers in neurology
Published: May 29, 2025

MONALISA: A Privacy-Preserving Infrastructure Supporting Liquid Biopsies to Monitor Relapsed Neuroblastoma.

MONALISA: A Privacy-Preserving Infrastructure Supporting Liquid Biopsies to Monitor Relapsed Neuroblastoma.

Journal: Studies in health technology and informatics
Published: May 17, 2025

Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical data.

Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical data.

Journal: Alzheimer's research & therapy
Published: November 18, 2024

ExoAccept: a holistic instrument to assess factors influencing acceptance of occupational exoskeletons.

ExoAccept: a holistic instrument to assess factors influencing acceptance of occupational exoskeletons.

Journal: Applied ergonomics
Published: July 08, 2024

Brain age as a biomarker for pathological versus healthy ageing - a REMEMBER study.

Brain age as a biomarker for pathological versus healthy ageing - a REMEMBER study.

Journal: Alzheimer's research & therapy
Published: April 02, 2024

Beyond CSF and Neuroimaging Assessment: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer's Disease.

Beyond CSF and Neuroimaging Assessment: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer's Disease.

Journal: ACS chemical neuroscience
Published: February 26, 2024

Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method.

Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method.

Journal: Alzheimer's research & therapy
Published: September 13, 2023

CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response.

CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response.

Journal: Alzheimer's research & therapy
Published: August 11, 2023

Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer's disease diagnosis.

Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer's disease diagnosis.

Journal: Neuroradiology
Published: July 18, 2023

Prognostic value of left ventricular global constructive work in patients with cardiac amyloidosis.

Prognostic value of left ventricular global constructive work in patients with cardiac amyloidosis.

Journal: The international journal of cardiovascular imaging
Published: November 19, 2022

Lead-exposure associated miRNAs in humans and Alzheimer's disease as potential biomarkers of the disease and disease processes.

Lead-exposure associated miRNAs in humans and Alzheimer's disease as potential biomarkers of the disease and disease processes.

Journal: Scientific reports
Published: February 25, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026